Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients
Clinical trial NCT04656262 · TERMINATED
Trial details
- NCT number
- NCT04656262
- Sponsor
- Istituto Oncologico Veneto IRCCS
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2024-05-23
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.